West Lafayette, IN, United States of America

Rush L Bartlett

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Purdue Research Foundation. Active years: 2016-2018.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rush L Bartlett: Innovator in Kinase Inhibiting Peptides

Introduction

Rush L Bartlett is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative treatments for inflammatory diseases. With a total of 2 patents, his work focuses on the delivery of kinase inhibiting peptides.

Latest Patents

Rush L Bartlett's latest patents include compositions and methods for the delivery of kinase inhibiting peptides. The invention relates to compositions and methods for the treatment of inflammatory disease states. In particular, the invention emphasizes the use of a nanoparticle incorporated kinase inhibiting peptide to treat these inflammatory conditions. This innovative approach aims to enhance the efficacy of treatments for patients suffering from various inflammatory diseases.

Career Highlights

Rush L Bartlett is associated with the Purdue Research Foundation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies in the medical field.

Collaborations

Some of his notable coworkers include Brandon Seal and Jamie L Brugnano. Their collaborative efforts contribute to the innovative research environment at Purdue Research Foundation.

Conclusion

Rush L Bartlett stands out as an influential inventor in the realm of kinase inhibiting peptides. His contributions to the treatment of inflammatory diseases highlight the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…